Efficient Down-Regulation of Glia Maturation Factor Expression in Mouse Brain and Spinal Cord

Long-lasting siRNA-based down-regulation of gene of interest can be achieved by lentiviral-based expression vectors driving the production of short hairpin RNA (shRNA). We investigated an attractive therapeutic approach to target the expression of proinflammatory GMF by using lentiviral vector encod...

Full description

Saved in:
Bibliographic Details
Published in:Neurochemical research 2012-07, Vol.37 (7), p.1578-1583
Main Authors: Zaheer, Smita, Wu, Yanghong, Yang, Xi, Thangavel, Ramasamy, Sahu, Shailendra K., Zaheer, Asgar
Format: Article
Language:English
Subjects:
Animals
Base Sequence
Biochemistry
Biomedical and Life Sciences
Biomedicine
Brain
Brain - metabolism
Cell Biology
Central nervous system
Down-Regulation
Enzyme-Linked Immunosorbent Assay
Experimental allergic encephalomyelitis
Expression vectors
Glia maturation factor
Glia Maturation Factor - metabolism
Inflammation
Mice
Mice, Inbred C57BL
Neurochemistry
Neurology
Neurosciences
Original Paper
RNA
RNA, Small Interfering
Spinal cord
Spinal Cord - metabolism
Thorax
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Long-lasting siRNA-based down-regulation of gene of interest can be achieved by lentiviral-based expression vectors driving the production of short hairpin RNA (shRNA). We investigated an attractive therapeutic approach to target the expression of proinflammatory GMF by using lentiviral vector encoding GMF–specific shRNA to reduce GMF levels in the spinal cord and brain of mice. To determine the effect of GMF–shRNA on GMF protein levels, we performed quantitative ELISA analysis in brain and in thoracic, cervical and lumbar regions of spinal cord from mice followed by GMF–shRNA (G-shRNA) or control shRNA (C-shRNA) treatments. Our results show a marked reduction of GMF protein levels in brain and spinal cord of mice treated with GMF–shRNA compared to control shRNA treatment. Consistent with the GMF protein analysis, the immunohistochemical examination of the spinal cord sections of EAE mice treated with GMF–shRNA showed significantly reduced GMF-immunoreactivity. Thus, the down-regulation of GMF by GMF–shRNA was efficient and wide spread in CNS as evident by the significantly reduced levels of GMF protein in the brain and spinal cord of mice.
ISSN:0364-3190
1573-6903
DOI:10.1007/s11064-012-0753-x